Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

LDL receptor upregulators emerge from joint Tularik/Sumitomo program

Oct. 29, 2001

New chroman derivatives designed at Akzo Nobel with affinity for estrogen receptors

Oct. 26, 2001

Amgen submits supplemental application with EMEA for anemia product

Oct. 26, 2001

Bayer presents new compounds stimulating erythropoiesis

Oct. 25, 2001

Genzyme receives FDA complete response letter for Fabrazyme

Oct. 25, 2001

Novo Nordisk makes further investment in Aradigm's AERx iDMS program

Oct. 25, 2001

Replagal therapy for Fabry's disease approved in New Zealand and Iceland

Oct. 25, 2001

Condensed thiazolamines from Novartis act as antagonists at the Y5 receptor

Oct. 24, 2001

Three related series of anorectic agents described by Aventis

Oct. 24, 2001

Several clinical studies evaluate metformin in PCOS

Oct. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...